Published by Coherent Market Insights
Posted on October 1, 2021
4 min readLast updated: February 1, 2026
Gene synthesis is crucial in synthetic biology, offering faster alternatives to cloning. Rising demand in pharmaceuticals and COVID-19 research boosts market growth.
In the recent past, gene synthesis has emerged as a new application of genetic engineering, and plays an important role in the field of synthetic biology. Gene synthesis is chemically in vitro synthesis of double-stranded DNA molecules. It is frequently far faster, straightforward, and less costly than using alternative methods of molecular cloning and mutagenesis. Moreover, the technology has now become a significant tool in various fields, including gene therapy, molecular engineering, vaccine development, and heterologous gene expression. Thus, there is an increasing demand for gene synthesis across the pharmaceutical industry. This in turn is expected to augment the gene synthesis market growth.
Request Sample Copy of This Report @
https://www.coherentmarketinsights.com/insight/request-sample/1533
For example, in August 2020, Codex DNA, introduced next-generation platform, the BioXp 3250 system. The system help reduce the timelines for identifying vaccine and biologic drug candidates from weeks to days by automatically performing the steps necessary to synthesize, assemble, and clone synthetic genes in a single overnight run. Gene synthesis, also known as artificial gene synthesis, refers to a set of biological approaches that are utilized in the field of synthetic biology to build and assemble genetic organisms from nucleotides without the need for natural selection. This method has made it possible to engineer potentially all of the living things that have a genetic material – all life.
Now with the advent of synthetic genetic technologies and modern biotechnology, it is possible to engineer plants, animals, and even bacteria. Moreover, gene synthesis enables creation and modification of genetic sequences at an unprecedented pace. It is the chemical synthesis of a DNA sequence that represents one or more genes. Thus, there is an increasing demand for this new technology. For example, in June 2019, GenScript announced a significant upgrade to its GenBrick Gene Synthesis platform, bringing researchers access to DNA sequences up to 200kb long with 100 percent accuracy.
Building on GenScript’s expertise in molecular biology and gene synthesis, GenBrick employs a newly developed proprietary technology for accurate and efficient one-step DNA assembly. This in turn is also expected to accelerate the growth of the gene synthesis market. Moreover, growth of the gene synthesis market is also driven by the emergence of COVID-19 (the global pandemic). DNA synthesis is one of the pillars of COVID-19 research that has suffered supply disruptions during lockdown. For example, in December 2020, Codex DNA released new synthetic SARS-CoV-2 genomes for use in the development of vaccines, therapeutics, and diagnostics to help in the COVID-19 pandemic response.
Major Players in Gene Synthesis Market
Atum, ATDBio Ltd., Bioneer Corporation, Eurofins Scientific, Eurogentec, GenScript Biotech Corporation, Genewiz, Integrated DNA Technologies, Inc., OriGene Technologies, Inc., and Thermo Fisher Scientific, Inc.
Ask for PDF sample copy of the Gene Synthesis market report @
https://www.coherentmarketinsights.com/insight/request-pdf/1533
Why this is Important Report to you? It helps:
• To analyze and study the Global Gene Synthesis Market capacity, production, value, consumption, status Focuses on the Key Gene Synthesis manufacturers, to study the capacity, production, value, market share and development plans in future.
• Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
• To define, describe and forecast the market by type, application, and region.
• To analyze the global and key regions market potential and advantage, opportunity, and challenge, restraints, and risks.
• To identify significant trends and factors driving or inhibiting market growth.
• To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the Gene Synthesis Market.
• To strategically profile the key players and comprehensively analyze their growth strategies.
• It provides a forward-looking perspective on different factors driving or restraining Market growth.
• It provides a six-year forecast assessed on the basis of how the Market is predicted to grow.
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors.
• It helps in making informed business decisions by having complete insights and by making an in-depth analysis of Market segment
Buy This Complete A Business Report With Flat US $2000 Off @
https://www.coherentmarketinsights.com/promo/buynow/1533
Contact:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com
The post Gene Synthesis Market Present New Data and Future Scope | Atum, ATDBio Ltd., Bioneer Corporation, Eurofins Scientific, Eurogentec appeared first on Gatorledger.
The article focuses on the growth and future scope of the Gene Synthesis Market.
Gene synthesis is important for its role in synthetic biology, offering faster and cost-effective alternatives to traditional methods.
COVID-19 has accelerated market growth by increasing demand for DNA synthesis in vaccine and therapeutic development.
Explore more articles in the Research Reports category
